Rayne Rodgers

Rayne has over eleven years of experience in patient advocacy, clinical trial recruitment, data science innovation, and program management. Prior to Kinevant, Rayne worked with the Muscular Dystrophy Association as the Vice President of MOVR – a unified, national patient data hub for neuromuscular diseases – facilitating research initiatives with pharmaceutical and academic partners. Before MDA, Rayne led global patient recruitment and advocacy efforts at miRagen Therapeutics across multiple rare hematological malignancies as the Director of Medical and Patient Affairs. Rayne was also a Program Manager at Takeda where she launched a novel, systematic study of exceptional drug responders to oncology treatments, in collaboration with Harvard Medical School.

Rayne earned a BS in Finance from the University of Florida and an MPH from Emory University.